XML 25 R11.htm IDEA: XBRL DOCUMENT v3.22.2.2
Inventories, Net
9 Months Ended
Sep. 30, 2022
Inventory Disclosure [Abstract]  
Inventories, net

4. Inventories, net

The following table presents inventories, net (in thousands):

 

 

 

September 30, 2022

 

 

December 31, 2021

 

Raw materials

 

$

29,170

 

 

$

26,637

 

Work-in-process

 

 

20,902

 

 

 

14,748

 

Finished goods

 

 

52,537

 

 

 

19,950

 

Total

 

$

102,609

 

 

$

61,335

 

 

As of September 30, 2022 and December 31, 2021, included in finished goods inventory was $42.2 million and $1.3 million of CpG 1018 adjuvant inventory, respectively. As of September 30, 2022 and December 31, 2021, included in finished goods inventory was $10.3 million and $18.6 million of HEPLISAV-B inventory, respectively.

 

We recorded prepaid manufacturing costs related to prepayments made to third-party manufacturers of CpG 1018 adjuvant, of $12.7 million and $159.7 million as of September 30, 2022 and December 31, 2021, respectively. We expect these costs to be converted into inventory within the next twelve months. As of September 30, 2022, we recorded $14.5 million of inventory write-off to cost of sales - product, in connection with the first amendment of the Clover Supply Agreement (See Note 6).